IR
Superintel
Overview
Markets
Watchlist
More
Regulus Therapeutics Inc
CUSIP: 75915K951 | 5 institutional holders
Watch
Quarters
Q3 2018
Q3 2017
Q2 2017
Q1 2017
Q4 2016
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile